VG Life Sciences Inc. (VGLS)

VG Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Net Income	-4.3	-6.19	-7.42	-6.85	-5.42	-7.24
Other Amortization	1.85	2.48	1.02	3.7	0.12	0.02
Stock-Based Compensation	0.31	0.72	1.5	0.2	1.47	0.59
Other Operating Activities	1.41	1.28	0.94	0.06	1.59	5.01
Change in Accounts Payable	0.01	0.32	0.07	0.2	0.06	0.04
Change in Other Net Operating Assets	-0.11	-0.48	2.9	1.83	1.23	0.57
Operating Cash Flow	-0.86	-1.91	-1.04	-0.96	-1.02	-1.01
Short-Term Debt Issued	-	-	0.13	-	-	-
Long-Term Debt Issued	-	1.28	1.83	1.12	0.86	0.69
Total Debt Issued	0.92	1.28	1.95	1.12	0.86	0.69
Long-Term Debt Repaid	-	-0.06	-0.21	-0.29	-0.42	-0.36
Net Debt Issued (Repaid)	0.82	1.23	1.75	0.83	0.44	0.33
Issuance of Common Stock	-	-	-	0.13	0.09	0.57
Other Financing Activities	0.01	-	-	-	0.49	0.1
Financing Cash Flow	0.83	1.23	1.75	0.96	1.02	1
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0	-
Net Cash Flow	-0.03	-0.68	0.71	0	-0	-0.01
Free Cash Flow	-0.86	-1.91	-1.04	-0.96	-1.02	-1.01
Free Cash Flow Margin	-	-	-	-	-	-17808.00%
Free Cash Flow Per Share	-0.01	-0.07	-0.13	-0.45	-0.83	-1.09
Levered Free Cash Flow	-1.46	-2.41	0.74	0.29	-1.77	-2.78
Unlevered Free Cash Flow	-2.03	-3.16	0.4	-1.06	-1	-0.98
Change in Working Capital	-0.1	-0.16	2.98	2.03	1.29	0.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.